By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Orchard Therapeutics 

5 Cheapside

London    EC2V 6AA  United Kingdom
Phone: 44-0-20-3823-2149 Fax: n/a


Orchard Therapeutics is a biotechnology company focused on the development and commercialisation of transformative ex-vivo gene therapies for patients with orphan diseases. Visit for more information.


May 2016


CMO: Andrea Spezzi

CSO: Bobby Gaspar

Chief Manufacturing Officer: Stewart Craig

SVP Business Operations: Nicolas Koebel


Please click here for Orchard Therapeutics's pipeline.

Key Statistics

Ownership: Private

Web Site: Orchard Therapeutics


Company News
Former PTC Therapeutics (PTCT) Exec Jumps Ship to Orchard Therapeutics as CEO 8/10/2017 6:06:20 AM
Orchard Therapeutics Announces That OTL-101 Has Received a Rare Paediatric Disease Designation 7/24/2017 1:14:47 PM
Orchard Therapeutics Announces A Manufacturing Services Agreement With PCT Cell Therapy Services, LLC 5/30/2017 12:40:13 PM
Orchard Therapeutics Announces A Manufacturing Alliance With PharmaCell BV 1/9/2017 10:34:33 AM
Orchard Therapeutics Announces Strategic Alliance With Oxford BioMedica PLC (OXB.L) 11/29/2016 8:48:34 AM
Orchard Therapeutics And UCLA Receive $20 Million In Latest Round Of Funding From California's Stem Cell Agency 11/23/2016 8:40:35 AM
UK's Orchard Therapeutics to Open Up Shop in the Bay Area 10/6/2016 5:39:22 AM
Orchard Therapeutics Announces Presentations From University College London/GOSH And UCLA Academic Collaborators On Clinical Data In ADA-SCID Using Ex-Vivo Lentiviral Gene Therapy At September 2016 ESID And ESGCT Congresses 9/21/2016 3:19:11 PM